Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe webpage has updated its date references, removing several past dates and adding new ones for 2025, indicating a shift in the timeline of events or updates.SummaryDifference0.9%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check47 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check68 days agoChange DetectedThe website has updated its contact information for several medical professionals and revised the intervention type, moving from version 2.13.3 to 2.14.0.SummaryDifference3%
Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.